Showing results (61-70 of 196) with videos related to

Sort By:
Pageof 20
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2018
Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practiceShinsuke Uchikawa, Tomokazu Kawaoka, Hiroshi Aikata, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Metabolism and pharmacokinetics of the anti-hepatitis C virus nucleotide prodrug GS-6620Eisuke Murakami, Ting Wang, Darius Babusis, et al.
Journal of Gastroenterology|September 6, 2019
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosisMaiko Namba, Akira Hiramatsu, Hiroshi Aikata, et al.
Journal of Gastroenterology and Hepatology|May 19, 2025
Clinical Significance of Small-Bowel Mucosal Changes in Liver Cirrhosis Patients With Suspected Small-Bowel Bleeding: A Capsule Endoscopy StudyYuka Matsubara, Akiyoshi Tsuboi, Shuya Shigenobu, et al.
Journal of Gastroenterology|January 22, 2025
Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis BMasanari Kosaka, Hatsue Fujino, Masataka Tsuge, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 17, 2024
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinomaShinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami, et al.
BMC Gastroenterology|October 26, 2019
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitisHatsue Fujino, Mio Tanaka, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 26, 2024
Time trend of outcomes according to systemic therapy for patients with unresectable hepatocellular carcinoma: A single-institution studyShinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami, et al.
Journal of Medicinal Chemistry|October 2, 2013
Use of 2'-spirocyclic ethers in HCV nucleoside designJinfa Du, Byoung-Kwon Chun, Ralph T Mosley, et al.
Pageof 20